Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
30.34
-0.25 (-0.82%)
At close: Jul 4, 2025, 2:57 PM CST
SHE:301166 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,062 | 1,118 | 1,226 | 1,195 | 1,110 | 849.08 | Upgrade
|
1,062 | 1,118 | 1,226 | 1,195 | 1,110 | 849.08 | Upgrade
| |
Revenue Growth (YoY) | -13.15% | -8.82% | 2.57% | 7.70% | 30.69% | 7.90% | Upgrade
|
Cost of Revenue | 874.31 | 916.48 | 995.73 | 930.56 | 852.59 | 657.08 | Upgrade
|
Gross Profit | 188.19 | 201.28 | 230.1 | 264.56 | 257.08 | 192 | Upgrade
|
Selling, General & Admin | 165.14 | 167.86 | 173.8 | 134.14 | 109.06 | 91.22 | Upgrade
|
Research & Development | 61.26 | 61.31 | 56.62 | 32.14 | 16.31 | 8.73 | Upgrade
|
Other Operating Expenses | 4.26 | 3.88 | 2.15 | 1.25 | 3.38 | 2.98 | Upgrade
|
Operating Expenses | 235.1 | 239.19 | 236.31 | 178.74 | 131.75 | 105.87 | Upgrade
|
Operating Income | -46.91 | -37.91 | -6.21 | 85.82 | 125.33 | 86.12 | Upgrade
|
Interest Expense | -1.04 | -1.04 | -2.06 | -1.29 | -0.11 | -0.39 | Upgrade
|
Interest & Investment Income | 22.62 | 23.74 | 24.99 | 27.11 | 3.53 | 2.82 | Upgrade
|
Currency Exchange Gain (Loss) | -2.11 | -2.11 | -3.24 | -2.83 | 0.22 | 2.1 | Upgrade
|
Other Non Operating Income (Expenses) | -2.37 | -0.29 | -0.47 | -0.52 | -0.36 | -0.41 | Upgrade
|
EBT Excluding Unusual Items | -29.81 | -17.61 | 13.01 | 108.29 | 128.61 | 90.25 | Upgrade
|
Gain (Loss) on Sale of Investments | 12.62 | 13.91 | 15.24 | 14.5 | - | -0.22 | Upgrade
|
Gain (Loss) on Sale of Assets | -1.54 | -1.24 | -0 | 0.01 | -0.24 | - | Upgrade
|
Asset Writedown | -0.92 | -0 | -0 | - | - | - | Upgrade
|
Other Unusual Items | 5.76 | 5.76 | 7.24 | 5.72 | 9.29 | 5.7 | Upgrade
|
Pretax Income | -13.89 | 0.82 | 35.48 | 128.52 | 137.65 | 95.74 | Upgrade
|
Income Tax Expense | -12.63 | -9.33 | -4.84 | 21.92 | 28.93 | 19.25 | Upgrade
|
Net Income | -1.26 | 10.15 | 40.32 | 106.6 | 108.73 | 76.49 | Upgrade
|
Net Income to Common | -1.26 | 10.15 | 40.32 | 106.6 | 108.73 | 76.49 | Upgrade
|
Net Income Growth | - | -74.83% | -62.18% | -1.96% | 42.15% | 32.01% | Upgrade
|
Shares Outstanding (Basic) | 85 | 85 | 86 | 87 | 65 | 65 | Upgrade
|
Shares Outstanding (Diluted) | 85 | 85 | 86 | 87 | 65 | 65 | Upgrade
|
Shares Change (YoY) | 0.02% | -1.41% | -1.02% | 32.32% | 1.05% | 4.04% | Upgrade
|
EPS (Basic) | -0.01 | 0.12 | 0.47 | 1.23 | 1.66 | 1.18 | Upgrade
|
EPS (Diluted) | -0.01 | 0.12 | 0.47 | 1.23 | 1.66 | 1.18 | Upgrade
|
EPS Growth | - | -74.47% | -61.79% | -25.90% | 40.68% | 26.88% | Upgrade
|
Free Cash Flow | 31.57 | 4.77 | -85.87 | -204.8 | 44.72 | 87.28 | Upgrade
|
Free Cash Flow Per Share | 0.37 | 0.06 | -1.00 | -2.36 | 0.68 | 1.35 | Upgrade
|
Dividend Per Share | 0.230 | 0.230 | 0.470 | 0.900 | 0.500 | - | Upgrade
|
Dividend Growth | -51.06% | -51.06% | -47.78% | 80.00% | - | - | Upgrade
|
Gross Margin | 17.71% | 18.01% | 18.77% | 22.14% | 23.17% | 22.61% | Upgrade
|
Operating Margin | -4.42% | -3.39% | -0.51% | 7.18% | 11.29% | 10.14% | Upgrade
|
Profit Margin | -0.12% | 0.91% | 3.29% | 8.92% | 9.80% | 9.01% | Upgrade
|
Free Cash Flow Margin | 2.97% | 0.43% | -7.00% | -17.14% | 4.03% | 10.28% | Upgrade
|
EBITDA | -32.44 | -24.21 | 4.39 | 92.32 | 130.52 | 92.34 | Upgrade
|
EBITDA Margin | -3.05% | -2.17% | 0.36% | 7.72% | 11.76% | 10.88% | Upgrade
|
D&A For EBITDA | 14.47 | 13.7 | 10.6 | 6.5 | 5.19 | 6.22 | Upgrade
|
EBIT | -46.91 | -37.91 | -6.21 | 85.82 | 125.33 | 86.12 | Upgrade
|
EBIT Margin | -4.42% | -3.39% | -0.51% | 7.18% | 11.29% | 10.14% | Upgrade
|
Effective Tax Rate | - | - | - | 17.05% | 21.01% | 20.11% | Upgrade
|
Revenue as Reported | 1,062 | 1,118 | 1,226 | 1,195 | 1,110 | 849.08 | Upgrade
|
Advertising Expenses | - | 4.05 | 9.56 | 5.81 | 5.08 | 3.53 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.